Spinnaker Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $730K | Buy |
1,469
+11
| +0.8% | +$4.88K | 0.04% | 180 |
|
|
2026
Q1 | $651K | Hold |
1,458
| – | – | 0.04% | 180 |
|
|
2025
Q4 | $661K | Sell |
1,458
-47
| -3% | -$20.3K | 0.04% | 178 |
|
|
2025
Q3 | $589K | Hold |
1,505
| – | – | 0.03% | 190 |
|
|
2025
Q2 | $670K | Buy |
1,505
+260
| +21% | +$120K | 0.04% | 180 |
|
|
2025
Q1 | $604K | Buy |
1,245
+10
| +0.8% | +$4.66K | 0.04% | 185 |
|
|
2024
Q4 | $497K | Buy |
1,235
+25
| +2% | +$11.6K | 0.03% | 196 |
|
|
2024
Q3 | $563K | Hold |
1,210
| – | – | 0.03% | 187 |
|
|
2024
Q2 | $567K | Hold |
1,210
| – | – | 0.04% | 186 |
|
|
2024
Q1 | $506K | Hold |
1,210
| – | – | 0.03% | 193 |
|
|
2023
Q4 | $492K | Hold |
1,210
| – | – | 0.03% | 188 |
|
|
2023
Q3 | $421K | Hold |
1,210
| – | – | 0.03% | 192 |
|
|
2023
Q2 | $426K | Hold |
1,210
| – | – | 0.03% | 186 |
|
|
2023
Q1 | $381K | Hold |
1,210
| – | – | 0.03% | 190 |
|
|
2022
Q4 | $349K | Hold |
1,210
| – | – | 0.03% | 215 |
|
|
2022
Q3 | $350K | Hold |
1,210
| – | – | 0.03% | 206 |
|
|
2022
Q2 | $341K | Sell |
1,210
-20
| -2% | -$5.35K | 0.03% | 218 |
|
|
2022
Q1 | $321K | Hold |
1,230
| – | – | 0.02% | 227 |
|
|
2021
Q4 | $270K | Hold |
1,230
| – | – | 0.02% | 248 |
|
|
2021
Q3 | $223K | Sell |
1,230
-1,400
| -53% | -$273K | 0.02% | 256 |
|
|
2021
Q2 | $530K | Hold |
2,630
| – | – | 0.04% | 183 |
|
|
2021
Q1 | $565K | Hold |
2,630
| – | – | 0.04% | 161 |
|
|
2020
Q4 | $621K | Buy |
2,630
+1,400
| +114% | +$321K | 0.05% | 149 |
|
|
2020
Q3 | $334K | Buy |
1,230
+120
| +11% | +$33.1K | 0.03% | 181 |
|
|
2020
Q2 | $322K | Hold |
1,110
| – | – | 0.03% | 183 |
|
|
2020
Q1 | $264K | Hold |
1,110
| – | – | 0.03% | 201 |
|
|
2019
Q4 | $243K | Buy |
+1,110
| New | +$225K | 0.02% | 227 |
|
|
2019
Q3 | – | Sell |
-1,110
| Closed | -$203K | – | 242 |
|
|
2019
Q2 | $203K | Sell |
1,110
-20
| -2% | -$3.5K | 0.02% | 227 |
|
|
2019
Q1 | $207K | Buy |
+1,130
| New | +$209K | 0.02% | 229 |
|
|
2018
Q4 | – | Sell |
-1,130
| Closed | -$217K | – | 235 |
|
|
2018
Q3 | $217K | Buy |
+1,130
| New | +$201K | 0.02% | 216 |
|
Other funds holding VRTX
Spinnaker Trust's VRTX Position: Q2 2026 in Review
Spinnaker Trust increased its Vertex Pharmaceuticals (VRTX) stake by 0.75% in Q2 2026, buying an estimated $4.88K and bringing the position to 1,469 shares worth $730K. The position accounts for 0.04% of the portfolio, ranked #180.
Spinnaker Trust first reported a position in VRTX in Q3 2018 and has held it in 30 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Spinnaker Trust held 1,469 shares of Vertex Pharmaceuticals worth $730K as of Q2 2026.
- Spinnaker Trust bought 11 Vertex Pharmaceuticals shares in Q2 2026, an estimated $4.88K.
- Vertex Pharmaceuticals made up 0.04% of Spinnaker Trust's portfolio in Q2 2026, its #180 holding.
- Spinnaker Trust first reported a position in Vertex Pharmaceuticals in Q3 2018 and has held it in 30 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Spinnaker Trust's 13F filing for Q2 2026, filed 3 Aug 2026.